Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
|ClinicalTrials.gov Identifier: NCT00605943|
Recruitment Status : Completed
First Posted : January 31, 2008
Last Update Posted : July 2, 2017
National Eye Institute (NEI)
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||August 4, 2009|
|Actual Study Completion Date :||August 4, 2009|
Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol. 2006 Dec;90(12):1542-7. Review.
Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond). 2008 Jan;22(1):42-8. Epub 2006 Jul 7.